News & Events
Sunday Shoyele, PhD, Receives Funding to Develop Novel Drug Delivery Technology
Dr. Sunday Shoyele, Assistant Professor of Pharmaceutical Sciences, has received a QED award from the University City Science Center of Philadelphia to support the development of a novel technology for delivering highly-degradable gene inhibitors to cancer and other cells using antibody-based nanoparticples. Dr. Shoyele was one of four researchers from an applicant pool of 68 applicants representing 9 universities in the Greater Philadelphia region. The Science Center’s QED Proof-of-Concept Program funds novel university technologies with market potential, bridging the gap between academic research and product commercialization. Dr. Shoyele will receive $100,000 from the Science Center and $100,000 matching funds from the Jefferson Innovation Pillar as well as guidance from an experienced team of business advisors to support the next steps in the development of his technology. Drs. Bo Lu, Professor in the Department of Radiation Oncology from the Sidney Kimmel Medical College and Asha Lakshmikuttyamma, Assistant Professor of Pharmaceutical Sciences are collaborating with Dr. Shoyele on this project.